RBD-BRIDGE™
About

An international initiative for rare bone disease imaging

How RBD-IBI is organised, what it exists to do, and who it works for.

Our mission

Measurement that changes lives.

Rare bone diseases affect small numbers of people in any one place, which is why progress has historically been slow. RBD-IBI is designed to make the field measurable — through quantitative imaging biomarkers that can be compared across centres, studies and countries.

Designed to unite shared pathology, shared imaging and shared data, common protocols and open evidence will help discoveries in one country benefit people everywhere — equally and openly.

Our charter

Research. Hope. Earlier Answers.

The identity that holds RBD-IBI together — an independent, international, clinician-led and platform-independent initiative advancing Imaging Biomarker Science for Rare Bone Diseases.

Research

Rigorous, shared and reproducible science — the only credible route from insight to earlier answers.

Hope

Built for people living with rare bone diseases and the families who care for them.

Earlier Answers

Objective measurement that gets people answers sooner — earlier diagnosis, earlier monitoring, earlier evaluation of therapies.

Charter, mission & vision

The Charter, mission, vision and principles below govern how the Initiative works — and who it answers to.

What we stand for

The guardrails for how we work.

Research integrity

Research that is registered, reproducible and honestly reported — evidence you can trust.

Open collaboration

Open methods and shared credit across the network — science moves faster together.

Global equity

The same science and opportunity for every country, not only the well-resourced.

Patient-centred

Research designed with patients and families — not merely about them.

How we work

A phased, transparent approach.

Ambition is designed to be delivered in phases — each one building openly on the last.

  • Phase 01 — Foundation: definitions, governance and core standards
  • Phase 02 — Data: shared acquisition protocols and datasets
  • Phase 03 — Validation: studies and clinical translation
  • Phase 04 — Scale: global adoption and evaluation
Read about the framework

Quick facts

  • Rare Bone Disease Imaging Biomarker Initiative (RBD-IBI)
  • International by design — small numbers anywhere, united by shared methods
  • Bringing science, care and communities together
  • A flagship digital platform: RBD-BRIDGE™ (in development)